The stock now trades at a dividend yield of 6.5%. Despite continued pricing pressure, Pfizer stock looks cheap for investors ...

Pfizer Inc. Q4 shows post-COVID growth, Seagen-fueled oncology gains, and obesity upside. Click for this updated look at PFE ...

Pfizer has reached a turning point.

Pfizer has reached a transition point following declines of some of its biggest blockbusters. The pharma giant is paving the way to growth through new products and acquisitions. 10 stocks we like ...

If you are wondering whether Pfizer's current share price reflects its long term potential or lingering concerns, looking ...

Shares of Pfizer Inc. PFE rallied 1.65% to $27.05 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and Dow ...

Pfizer (PFE) looks undervalued at 8–9x forward earnings with a ~7% yield; see how Seagen, cost cuts and the pipeline could ...

Pfizer (PFE) ended the recent trading session at $26.86, demonstrating a -1.61% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 1.52% for ...

The stock is down, but the good news is that it sports a fat dividend yield of 6.4%. Pfizer has been struggling lately, but ...